project id: TCGA-COAD; case submitter id: TCGA-A6-5664; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 80; days to birth: -29426; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1930; age at diagnosis: 29426; ajcc pathologic m: MX; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 672.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Colon, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.3; oct embedded: No; shortest dimension: 0.8; portion submitter id: TCGA-A6-5664-01A-21; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 1.0; percent necrosis: 4.0; percent neutrophil infiltration: 1.0; percent normal cells: 30.0; percent stromal cells: 0.0; percent tumor cells: 66.0; percent tumor nuclei: 70.0;